Roche Registration Ltd.
- B03 - Preparados antianémicos
- MIRCERA solution for injection 1 000 µg/1 ml
- MIRCERA solution for injection 100 µg/0.3 ml
- MIRCERA solution for injection 100 µg/1 ml
- MIRCERA solution for injection 150 µg/0.3 ml
- MIRCERA solution for injection 200 µg/0.3 ml
- MIRCERA solution for injection 200 µg/1 ml
- MIRCERA solution for injection 250 µg/0.3 ml
- MIRCERA solution for injection 300 µg/1 ml
- MIRCERA solution for injection 400 µg/0.6 ml
- MIRCERA solution for injection 400 µg/1 ml
- MIRCERA solution for injection 50 µg/0.3 ml
- MIRCERA solution for injection 50 µg/1 ml
- MIRCERA solution for injection 600 µg/0.6 ml
- MIRCERA solution for injection 600 µg/1 ml
- MIRCERA solution for injection 75 µg/0.3 ml
- MIRCERA solution for injection 800 µg/0.6 ml
- NEORECORMON powder and solvent for solution for injection 500 IU(4.15 µg)+0.5 ml
- NEORECORMON PREFILLED SYRINGE solution for injection 30 000 IU(249 µg)/0.6 ml
- M05 - Preparados para el tratamiento de enfermedades óseas
- BONDENZA film-coated tablet 150 mg
- BONDENZA film-coated tablet 2.5 mg
- BONDENZA solution for injection 3 mg/3 ml